Increased microRNA-34c abundance in Alzheimer's disease circulating blood plasma. - Wikidata - wikimedia - TriplyDB

Increased microRNA-34c abundance in Alzheimer's disease circulating blood plasma.

Increased microRNA-34c abundance in Alzheimer's disease circulating blood plasma.

http://www.wikidata.org/entity/Q37549962

about

Diagnostic Value of microRNA for Alzheimer's Disease: A Systematic Review and Meta-Analysis Issues and prospects of microRNA-based biomarkers in blood and other body fluids Exploring Biomarkers for Alzheimer's Disease NIH workshop report on the trans-agency blood-brain interface workshop 2016: exploring key challenges and opportunities associated with the blood, brain and their interface.MicroRNA-Seq Data Analysis Pipeline to Identify Blood Biomarkers for Alzheimer's Disease from Public Data.Novel roles of non-coding brain RNAs in health and disease.Assay reproducibility in clinical studies of plasma miRNA Circulating MicroRNA as Potential Source for Neurodegenerative Diseases Biomarkers.Grouping Pentylenetetrazol-Induced Epileptic Rats According to Memory Impairment and MicroRNA Expression Profiles in the Hippocampus MicroRNAs: New Players in Anesthetic-Induced Developmental Neurotoxicity microRNA-34a-Mediated Down-Regulation of the Microglial-Enriched Triggering Receptor and Phagocytosis-Sensor TREM2 in Age-Related Macular Degeneration Vaspin regulates the osteogenic differentiation of MC3T3-E1 through the PI3K-Akt/miR-34c loop The potential role of epigenetic modulations in BPPV maneuver exercises.Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer's disease patients from non-demented subjects.Circulating miRNAs as biomarkers for neurodegenerative disorders.Dysregulation and diagnostic potential of microRNA in Alzheimer's disease.Alzheimer's Disease and ncRNAs.MicroRNA-34c Downregulation Ameliorates Amyloid-β-Induced Synaptic Failure and Memory Deficits by Targeting VAMP2.An overview of circulating cell-free microRNAs as putative biomarkers in Alzheimer's and Parkinson's Diseases.miR-34c regulates the permeability of blood-tumor barrier via MAZ-mediated expression changes of ZO-1, occludin, and claudin-5.miRNAs as biomarkers of neurodegenerative disorders.Alzheimer's Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid.Stress-induced changes in miRNA biogenesis and functioning.Deficits in the miRNA-34a-regulated endogenous TREM2 phagocytosis sensor-receptor in Alzheimer's disease (AD); an update Peripheral Signatures of Psychiatric Disorders: MicroRNAs.Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases.Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.Regulation of ADAM10 by miR-140-5p and potential relevance for Alzheimer's disease.Circulating microRNAs in Neurodegenerative Diseases.An Efficient Particle-Based DNA Circuit System: Catalytic Disassembly of DNA/PEG-Modified Gold Nanoparticle-Magnetic Bead Composites for Colorimetric Detection of miRNA.miRNA-34c Overexpression Causes Dendritic Loss and Memory Decline

P2860

Q26768181-BD5C0D0F-1B84-46AC-BB71-2F7E726A887D Q26991755-AF36D18C-AB78-483B-B8ED-AF075696E76D Q28079218-4F1784B0-95FB-4955-BDE8-01AD6D6F129F Q30352890-6B5AA5A7-5EC6-4FB2-8CD7-16BDCD50B256 Q30940333-06E129F6-053B-45AF-BF7D-1C22B62D4B4C Q33810656-1A4E2ABF-1ED0-463F-9CF4-FBF904AEEA90 Q35325816-494F5A84-AD77-43A3-8DFA-21AD85E54150 Q35390914-11B02484-EC86-41AC-88F7-5E97D0AD131A Q35593533-25BFDBA0-0FC6-4D5D-8C33-57B0C1C7797A Q35802248-FB97B658-B9DF-4A0C-9827-4A7436FB3F64 Q35947548-35B6A18D-1AC7-42DD-BA73-24E1EEAB3DB0 Q36882046-BEA03675-F332-42FB-8DDF-D92306BFC688 Q37392511-DF63AD2A-623B-4571-A43D-1C480721F51F Q37725397-2B6C6274-F3B8-4925-8B3A-486BEAFE4A88 Q38214427-62297705-A121-465D-A005-DF4A2FF30261 Q38612032-D6101DBF-7DDE-4275-A8BA-C1BEBE9097C3 Q38681920-D06B4F1A-5DEA-4AF9-88A4-14870E5059CC Q38832895-35639BE1-36DB-4AA8-B6FF-9D9620A795EB Q38887384-9705CCFD-E351-4C1E-94BB-0F996CFE9A5F Q38958450-1C18BEB4-C8BE-4D4A-A41C-0782992B22AB Q39104808-47F2CA45-A0BA-41B7-8615-3AC3CCC6E5F1 Q39217840-B9407C21-6BCE-4CDE-8B0C-7D9C95D59D46 Q39440775-D9AB3B4C-B471-4C9F-9811-49EDF370B02E Q40781085-2B1BF219-24DC-4ECB-B880-E016074E0C88 Q43705521-F98579C9-0ED4-4F18-A1EF-97D90E1C291F Q45325968-92F4ADA3-2529-4E5F-A8F6-00FE591834C9 Q46830133-EF947F04-4DD8-4420-9AF4-38F7057A67CB Q47908768-2BD7F289-C316-4388-9A1F-F37C9FDA9ECF Q48713195-E80AB5D9-7461-4062-A70A-520CFA2A7714 Q49141990-8F08A24C-A0AD-4F49-B533-28612B9D2AC7 Q58795107-D6181DFF-62F0-4DF5-A0BA-A7D100626D39

P2860

Increased microRNA-34c abundance in Alzheimer's disease circulating blood plasma.

http://www.wikidata.org/entity/Q37549962

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 04 February 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Increased microRNA-34c abundance in Alzheimer's disease circulating blood plasma.

@en

Increased microRNA-34c abundance in Alzheimer's disease circulating blood plasma.

@nl

type

label

Increased microRNA-34c abundance in Alzheimer's disease circulating blood plasma.

@en

Increased microRNA-34c abundance in Alzheimer's disease circulating blood plasma.

@nl

prefLabel

Increased microRNA-34c abundance in Alzheimer's disease circulating blood plasma.

@en

Increased microRNA-34c abundance in Alzheimer's disease circulating blood plasma.

@nl

P1433

Q37549962-3C6C4CBE-A25F-4B32-A356-B221920407F1

P1476

Q37549962-80515D72-800F-473E-997C-0F13525A15B7

P2093

Q37549962-5265EB95-7159-4C23-90D2-C99E0E2F7BC4

Q37549962-5F9C3566-1F44-4591-919C-2139FDD82C3F

Q37549962-65AA6CF3-9912-4B2A-AC10-66570AA1BD27

Q37549962-6E2EBF6D-B14B-4D93-BB5D-6C0315E67609

Q37549962-781267EE-DD07-44EA-85C2-3257D2CF244D

Q37549962-87DBE1F7-661D-4EC0-95C8-E841CD38813E

Q37549962-9A1F4607-E17C-4048-86CD-43DC278F469B

P2860

Q37549962-048A6E12-A788-4728-8316-31F799B1D978

Q37549962-0DE522B9-2BD6-4769-AC93-4B7FCD5FC887

Q37549962-1945021B-42A4-4B96-A052-8D0CDBE53022

Q37549962-247A871A-9970-4BB8-9EBC-2CA6D217A3AC

Q37549962-2A2FBE8A-FFD7-4EE9-B775-76FA1493AA99

Q37549962-320D6136-3815-449E-AF94-13203B979E63

Q37549962-34782CCD-ED09-4E39-ADD2-6074CFF2D8A5

Q37549962-36475F0A-88E2-4AAB-8BBF-EFE29E9F07DA

Q37549962-3785A182-7DF5-4992-9CE3-01BFD6A9AF05

Q37549962-3E8E3FB5-721A-4AB3-B722-602ACC8D5505

P304

Q37549962-E0E01243-52A0-4939-8A12-12055E09D54A

P31

Q37549962-8A7EE141-1CF0-4A13-A847-F49DFAB3B643

P356

Q37549962-BED7B39C-847B-4CD8-A78D-0560C0C3CACA

P478

Q37549962-8DE84F83-32DF-4394-B06D-59948D9A6A4E

P50

Q37549962-DB13FF27-BB0B-4326-80C2-E8EE55DF95AD

P577

Q37549962-8B7DE680-92EA-4690-8D5B-CCB123F95F30

P5875

Q37549962-4116BE21-C48E-4FFA-A986-7170DF94B215

P698

Q37549962-021AC292-F9AB-44E9-966A-E57FBE008D41

P921

Q37549962-6F8F3515-A00A-4EA1-AFED-88B116B2528D

Q37549962-BD8F3E77-4541-48EF-BA34-AD012994D7B0

P932

Q37549962-55375481-01A1-4FD5-A88B-7874EABBBDAD

P356

FNMOL.2014.00002

P1433

Frontiers in molecular neuroscience

P1476

Increased microRNA-34c abundance in Alzheimer's disease circulating blood plasma.

@en

P2093

Eugenia Wang

http://www.w3.org/2001/XMLSchema#string

Hyman M Schipper

http://www.w3.org/2001/XMLSchema#string

Samantha Jenkins

http://www.w3.org/2001/XMLSchema#string

Shephali Bhatnagar

http://www.w3.org/2001/XMLSchema#string

Timothy Jones

http://www.w3.org/2001/XMLSchema#string

Vikranth Shetty

http://www.w3.org/2001/XMLSchema#string

Zongfei Yuan

http://www.w3.org/2001/XMLSchema#string

P2860

miR-34a repression of SIRT1 regulates apoptosis

MicroRNA: Implications for Alzheimer Disease and other Human CNS Disorders

“Mini-mental state”

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Neuronal dark matter: the emerging role of microRNAs in neurodegeneration

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Control of liver cell fate decision by a gradient of TGF beta signaling modulated by Onecut transcription factors

A blood-based screening tool for Alzheimer's disease that spans serum and plasma: findings from TARC and ADNI

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment

P304

2

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FNMOL.2014.00002

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Howard Chertkow

P577

2014-02-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260254442

http://www.w3.org/2001/XMLSchema#string

P698

24550773

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3912349

http://www.w3.org/2001/XMLSchema#string